Biohit Oyj (Finland) Performance
| BIOBV Stock | EUR 2.35 0.02 0.86% |
Biohit Oyj has a performance score of 2 on a scale of 0 to 100. The firm shows a Beta (market volatility) of 0.0066, which signifies not very significant fluctuations relative to the market. As returns on the market increase, Biohit Oyj's returns are expected to increase less than the market. However, during the bear market, the loss of holding Biohit Oyj is expected to be smaller as well. Biohit Oyj B right now shows a risk of 2.23%. Please confirm Biohit Oyj B semi variance, and the relationship between the treynor ratio and daily balance of power , to decide if Biohit Oyj B will be following its price patterns.
Risk-Adjusted Performance
2 of 100
Weak | Strong |
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Biohit Oyj B are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite fairly strong technical indicators, Biohit Oyj is not utilizing all of its potentials. The recent stock price confusion, may contribute to short-horizon losses for the traders. ...more
| Begin Period Cash Flow | 1 M | |
| Total Cashflows From Investing Activities | 760 K |
Biohit |
Biohit Oyj Relative Risk vs. Return Landscape
If you would invest 228.00 in Biohit Oyj B on September 29, 2024 and sell it today you would earn a total of 7.00 from holding Biohit Oyj B or generate 3.07% return on investment over 90 days. Biohit Oyj B is generating 0.0739% of daily returns and assumes 2.2272% volatility on return distribution over the 90 days horizon. Simply put, 19% of stocks are less volatile than Biohit, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Biohit Oyj Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Biohit Oyj's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Biohit Oyj B, and traders can use it to determine the average amount a Biohit Oyj's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0332
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | BIOBV | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 2.23 actual daily | 19 81% of assets are more volatile |
Expected Return
| 0.07 actual daily | 1 99% of assets have higher returns |
Risk-Adjusted Return
| 0.03 actual daily | 2 98% of assets perform better |
Based on monthly moving average Biohit Oyj is performing at about 2% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Biohit Oyj by adding it to a well-diversified portfolio.
Biohit Oyj Fundamentals Growth
Biohit Stock prices reflect investors' perceptions of the future prospects and financial health of Biohit Oyj, and Biohit Oyj fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Biohit Stock performance.
| Return On Equity | 0.0645 | |||
| Return On Asset | 0.0652 | |||
| Profit Margin | 0.04 % | |||
| Operating Margin | 0.1 % | |||
| Current Valuation | 20.88 M | |||
| Shares Outstanding | 12.07 M | |||
| Price To Earning | 11.00 X | |||
| Price To Book | 3.28 X | |||
| Price To Sales | 2.16 X | |||
| Revenue | 9.36 M | |||
| EBITDA | 693 K | |||
| Cash And Equivalents | 9.38 M | |||
| Cash Per Share | 0.63 X | |||
| Total Debt | 59 K | |||
| Debt To Equity | 0.30 % | |||
| Book Value Per Share | 0.53 X | |||
| Cash Flow From Operations | (444 K) | |||
| Earnings Per Share | 0.03 X | |||
| Total Asset | 9.61 M | |||
| Retained Earnings | 6 M | |||
| Current Asset | 9 M | |||
| Current Liabilities | 1000 K | |||
About Biohit Oyj Performance
By evaluating Biohit Oyj's fundamental ratios, stakeholders can gain valuable insights into Biohit Oyj's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Biohit Oyj has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Biohit Oyj has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
Biohit Oyj, a biotechnology company, produces diagnostic tests and analysis systems for use in research institutions and healthcare industries worldwide. The company was founded in 1988 and is headquartered in Helsinki, Finland. Biohit Oyj operates under Healthcare Services classification in Finland and is traded on Helsinki Exchange. It employs 49 people.Things to note about Biohit Oyj B performance evaluation
Checking the ongoing alerts about Biohit Oyj for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Biohit Oyj B help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| The company reported the revenue of 9.36 M. Net Loss for the year was (1.5 M) with profit before overhead, payroll, taxes, and interest of 5.92 M. | |
| Biohit Oyj B has accumulated about 9.38 M in cash with (444 K) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.63. | |
| Roughly 47.0% of the company shares are held by company insiders |
- Analyzing Biohit Oyj's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Biohit Oyj's stock is overvalued or undervalued compared to its peers.
- Examining Biohit Oyj's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Biohit Oyj's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Biohit Oyj's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Biohit Oyj's stock. These opinions can provide insight into Biohit Oyj's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Biohit Stock analysis
When running Biohit Oyj's price analysis, check to measure Biohit Oyj's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biohit Oyj is operating at the current time. Most of Biohit Oyj's value examination focuses on studying past and present price action to predict the probability of Biohit Oyj's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biohit Oyj's price. Additionally, you may evaluate how the addition of Biohit Oyj to your portfolios can decrease your overall portfolio volatility.
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences |